AIMS/HYPOTHESIS: Elevated fasting and postprandial plasma levels of triglyceride-rich lipoproteins (TGRLs), i.e. VLDL/remnants and chylomicrons/remnants, are a characteristic feature of insulin resistance and are considered a consequence of this state. The aim of this study was to investigate whether intact TGRL particles are capable of inducing insulin resistance. METHODS: We studied the effect of highly purified TGRLs on glycogen synthesis, glycogen synthase activity, glucose uptake, insulin signalling and intramyocellular lipid (IMCL) content using fully differentiated L6 skeletal muscle cells. RESULTS: Incubation with TGRLs diminished insulin-stimulated glycogen synthesis, glycogen synthase activity, glucose uptake and insulin-stimulated phosphorylation of Akt and glycogen synthase kinase 3. Insulin-stimulated tyrosine phosphorylation of IRS-1, and IRS-1- and IRS-2-associated phosphatidylinositol 3-kinase (PI3K) activity were not impaired by TGRLs, suggesting that these steps were not involved in the lipoprotein-induced effects on glucose metabolism. The overall observed effects were time- and dose-dependent and paralleled IMCL accumulation. NEFA concentration in the incubation media did not increase in the presence of TGRLs indicating that the effects observed were solely due to intact lipoprotein particles. Moreover, co-incubation of TGRLs with orlistat, a potent active-site inhibitor of various lipases, did not alter TGRL-induced effects, whereas co-incubation with receptor-associated protein (RAP), which inhibits interaction of TGRL particles with members of the LDL receptor family, reversed the TGRL-induced effects on glycogen synthesis and insulin signalling. CONCLUSIONS/ INTERPRETATION: Our data suggest that the accumulation of TGRLs in the blood stream of insulin-resistant patients may not only be a consequence of insulin resistance but could also be a cause for it.
AIMS/HYPOTHESIS: Elevated fasting and postprandial plasma levels of triglyceride-rich lipoproteins (TGRLs), i.e. VLDL/remnants and chylomicrons/remnants, are a characteristic feature of insulin resistance and are considered a consequence of this state. The aim of this study was to investigate whether intact TGRL particles are capable of inducing insulin resistance. METHODS: We studied the effect of highly purified TGRLs on glycogen synthesis, glycogen synthase activity, glucose uptake, insulin signalling and intramyocellular lipid (IMCL) content using fully differentiated L6 skeletal muscle cells. RESULTS: Incubation with TGRLs diminished insulin-stimulated glycogen synthesis, glycogen synthase activity, glucose uptake and insulin-stimulated phosphorylation of Akt and glycogen synthase kinase 3. Insulin-stimulated tyrosine phosphorylation of IRS-1, and IRS-1- and IRS-2-associated phosphatidylinositol 3-kinase (PI3K) activity were not impaired by TGRLs, suggesting that these steps were not involved in the lipoprotein-induced effects on glucose metabolism. The overall observed effects were time- and dose-dependent and paralleled IMCL accumulation. NEFA concentration in the incubation media did not increase in the presence of TGRLs indicating that the effects observed were solely due to intact lipoprotein particles. Moreover, co-incubation of TGRLs with orlistat, a potent active-site inhibitor of various lipases, did not alter TGRL-induced effects, whereas co-incubation with receptor-associated protein (RAP), which inhibits interaction of TGRL particles with members of the LDL receptor family, reversed the TGRL-induced effects on glycogen synthesis and insulin signalling. CONCLUSIONS/ INTERPRETATION: Our data suggest that the accumulation of TGRLs in the blood stream of insulin-resistant patients may not only be a consequence of insulin resistance but could also be a cause for it.
Authors: D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien Journal: Diabetes Date: 1997-06 Impact factor: 9.461
Authors: I Usui; Y Takata; T Imamura; H Morioka; T Sasaoka; T Sawa; H Ishihara; M Ishiki; M Kobayashi Journal: Diabetologia Date: 1997-08 Impact factor: 10.122
Authors: M T Pedrini; A Niederwanger; M Kranebitter; C Tautermann; C Ciardi; T Tatarczyk; J R Patsch Journal: Diabetologia Date: 2006-04-26 Impact factor: 10.122
Authors: Warren H Capell; Isabel R Schlaepfer; Pamela Wolfe; Peter A Watson; Daniel H Bessesen; Michael J Pagliassotti; Robert H Eckel Journal: Am J Physiol Endocrinol Metab Date: 2010-07-13 Impact factor: 4.310
Authors: Cynthia A Nagle; Jie An; Masakazu Shiota; Tracy P Torres; Gary W Cline; Zhen-Xiang Liu; Shuli Wang; Reetta L Catlin; Gerald I Shulman; Christopher B Newgard; Rosalind A Coleman Journal: J Biol Chem Date: 2007-03-27 Impact factor: 5.157
Authors: Bin Cai; Wenjun Li; XiaoOu Mao; Ali Winters; Myoung-Gwi Ryou; Ran Liu; David A Greenberg; Ning Wang; Kunlin Jin; Shao-Hua Yang Journal: Mol Neurobiol Date: 2015-01-24 Impact factor: 5.590
Authors: Susanna M Hofmann; Li Zhou; Diego Perez-Tilve; Todd Greer; Erin Grant; Lauren Wancata; Andrew Thomas; Paul T Pfluger; Joshua E Basford; Dean Gilham; Joachim Herz; Matthias H Tschöp; David Y Hui Journal: J Clin Invest Date: 2007-11 Impact factor: 14.808
Authors: Tobias Tatarczyk; Christian Ciardi; Andreas Niederwanger; Michael Kranebitter; Josef R Patsch; Michael T Pedrini Journal: Mol Cell Endocrinol Date: 2011-06-15 Impact factor: 4.102
Authors: A Leon-Acuña; J F Alcala-Diaz; J Delgado-Lista; J D Torres-Peña; J Lopez-Moreno; A Camargo; A Garcia-Rios; C Marin; F Gomez-Delgado; J Caballero; B Van-Ommen; M M Malagon; P Perez-Martinez; J Lopez-Miranda Journal: Cardiovasc Diabetol Date: 2016-04-19 Impact factor: 9.951